Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Machine Learning-Based Permeability Prediction and Human Oral Exposure Projection of Beyond Rule of Five Compounds
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. Bayer AG. (Molecular Pharmaceutics / Preclinical Modeling & Simulation)
2023 (English)Independent thesis Advanced level (degree of Master (Two Years)), 30 credits / 45 HE creditsStudent thesis
Abstract [en]

With the current move from classical small molecules to new synthetic modalities, there is a strong need to predict the pharmacokinetics of beyond and extended rule of five (bRo5 & eRo5) compounds. The present master’s thesis introduces two machine learning models for classification and regression of Caco-2 permeability of compounds belonging to these bRo5 and ebRo5 categories, to support scientist in selection of compounds during the early drug discovery process. Different algorithms and descriptors are explored and the final regression and classification model evaluated. Additionally, an approach is developed to predict human oral exposures from key parameters such as clearance and permeability. Different clearance models are included and assessed by comparing resulting exposure projections to literature values, which revealed fundamental challenges related to reliable estimation of exposure. The presented permeability classification model can be used to categorize compounds according to three defined permeability classes and can therefore be a valuable tool for medicinal chemists in a drug discovery process, while the regression model can be helpful to avoid synthesis efforts of low permeable compounds.

Place, publisher, year, edition, pages
2023. , p. 27
Keywords [en]
ML, Ro5, bRo5, ebRo5, Caco-2, Permeability
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:uu:diva-504217OAI: oai:DiVA.org:uu-504217DiVA, id: diva2:1765809
External cooperation
Andreas Reichel, Bayer AG, Supervisor
Subject / course
Pharmacy
Educational program
Master's Programme in Pharmaceutical Modelling
Presentation
2023-05-31, Uppsala, 11:43 (English)
Supervisors
Examiners
Available from: 2023-06-15 Created: 2023-06-12 Last updated: 2023-06-15Bibliographically approved

Open Access in DiVA

No full text in DiVA

By organisation
Department of Pharmacy
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 214 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf